Colchicine Use for Primary Prevention of Coronary Artery Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 6792 participants.
Also called NCT05175274
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 6,792 participants
- Sponsor
- Registry
-
NCT05175274
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05175274. Randomized; double masking; primary purpose prevention. Start 2022-12-06 (anticipated); primary completion 2027-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine Use for Primary Prevention of Coronary Artery Disease
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Qingdao Central Hospital
- Collaborator
- Qingdao Municipal Hospital
Record details
- Record id
cardio:ct-nct05175274- Content hash
619cfe0f0a8947d63c715efda2bebf8f14abf33d7f3871b5c63337de923c95d6